ClinicalTrials.govpublic full text
Pembrolizumab and Chemotherapy Treatment or no Treatment Guided by the Level of TILs in Resected Early-stage TNBC
triple-negative breast cancer
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 256900
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.